Shares of Doximity, Inc. (NASDAQ:DOCS – Get Free Report) have earned a consensus rating of “Hold” from the eighteen analysts that are covering the stock, MarketBeat.com reports. Eleven investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $52.27.
A number of brokerages have recently issued reports on DOCS. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a report on Friday, November 8th. Wells Fargo & Company raised Doximity from an “underweight” rating to an “equal weight” rating and raised their price objective for the company from $19.00 to $41.00 in a research report on Friday, November 8th. JPMorgan Chase & Co. boosted their target price on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a report on Thursday, November 21st. Robert W. Baird raised their price target on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday, September 17th. Finally, Evercore ISI upped their price objective on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th.
Read Our Latest Stock Report on Doximity
Institutional Inflows and Outflows
Doximity Trading Down 0.7 %
NASDAQ DOCS opened at $53.00 on Monday. The firm has a market capitalization of $9.89 billion, a P/E ratio of 60.92, a price-to-earnings-growth ratio of 4.25 and a beta of 1.30. The firm’s fifty day moving average price is $45.86 and its two-hundred day moving average price is $36.09. Doximity has a 1 year low of $22.96 and a 1 year high of $61.75.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories
- Five stocks we like better than Doximity
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- EV Stocks and How to Profit from Them
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What is the Nasdaq? Complete Overview with History
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.